Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Free Report)’s stock price fell 1.5% during trading on Thursday . The stock traded as low as $0.14 and last traded at $0.14. 813 shares were traded during mid-day trading, a decline of 92% from the average session volume of 10,628 shares. The stock had previously closed at $0.15.
Guided Therapeutics Stock Performance
The company has a market cap of $9.30 million, a P/E ratio of -4.76 and a beta of 0.58. The company’s 50-day moving average price is $0.17 and its two-hundred day moving average price is $0.15.
Guided Therapeutics Company Profile
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Featured Stories
- Five stocks we like better than Guided Therapeutics
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Earnings Per Share Calculator: How to Calculate EPS
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Basic Materials Stocks Investing
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
